Federal contractor · NEW YORK, NY

INTERNATIONAL AIDS VACCINE INITIATIVE INC.

INTERNATIONAL AIDS VACCINE INITIATIVE INC. received $1M in federal contract obligations in FY2026, on 8 awards (−68% vs FY2025). Since FY2017: $152.5M. Its largest customer was National Institutes of Health ($1M). It also received $542.2K in federal grants and other assistance in FY2026.

Obligations · FY2026: $1M
New awards: 8
Sole-source: 0.0%
Single offer: 9.1%

UEI: ZEJBC8JQM3P5

Other than small businessNonprofit

Open in the contracts explorer Relationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

2.4MFY2017
4.3MFY2018
7.4MFY2019
1.2MFY2020
46.3MFY2021
26.3MFY2022
55.6MFY2023
4.9MFY2024
3.2MFY2025
1MFY2026

Top buying agencies

Obligations in FY2026.

National Institutes of Health$1M100%
7 awards
Office of Assistant Secretary for Preparedness and Response$00.0%
1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Research & development$1M100%

Where the work was performed

New York County, NY$1M100%

Integrity signals

Shares of the year's obligations, next to the country's.

Low competition9.1%
US 39% · $92.6K
Sole-source awards0.0%
US 30% · $0
Single-offer competitions9.1%
US 8.7% · $92.6K
Urgency justifications0.0%
US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN$95.6M
Office of Assistant Secretary for Preparedness and Response· New York County, NY· Research & development· Sep 30, 2021 – Jul 20, 2026· 75A50121C00077
PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS$8.4M
National Institutes of Health· New York County, NY· Research & development· Dec 1, 2021 – Jun 30, 2026· 75N93022F00001
1800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF HUMAN FLU CHALLENGE MATERIAL$4.2M
National Institutes of Health· New York County, NY· Research & development· Aug 28, 2018 – May 13, 2026· 75N93018F00002
CONTRACT HHSN272201800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE I AND II CLINICAL TESTING$3.6M
National Institutes of Health· New York County, NY· Research & development· Sep 26, 2023 – Dec 19, 2025· 75N93023F00001
THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE SURFACE OF THE LNP. A NON-GMP PROCESS RUN OF DRUG PRODUCT SHALL BE PERF$2.3M
National Institutes of Health· New York County, NY· Research & development· Aug 31, 2021 – Sep 28, 2026· 75N93021F00239
1800010I INTERNATIONAL AIDS VACCINE INITIATIVE TO V3 OBRA--2 BASE TASK ORDER FUNDING BIOD CAN 8470038 $642,953$2.2M
National Institutes of Health· New York County, NY· Research & development· Feb 28, 2019 – Sep 2, 2026· 75N93019F00131
HHSN272201800010I IAVI STORAGE OF GMP AND NON-GMP MATERIALS FOR NIAID BASE AWARD, CAN 8470038 FOR $435,313.50 CAN 8040917 FOR $435,313.50 TOTAL $870,627$963.2K
National Institutes of Health· New York County, NY· Research & development· Sep 14, 2021 – Sep 11, 2026· 75N93021F00001
NANOPARTICLE-BASED DEVELOPMENT FOR HIV-1 BIOMOLECULE DELIVERY$713.7K
National Institutes of Health· New York County, NY· Research & development· Aug 9, 2019 – Aug 21, 2026· 75N93019F00257

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

INTERNATIONAL AIDS VACCINE INITIATIVE INC. received $542.2K in federal assistance in FY2026, on 2 actions (0 new awards), −19% vs FY2025. Its largest program was 93.855 · Allergy and Infectious Diseases Research ($542.2K).

Assistance · FY2026: $542.2K
New awards: 0
Actions: 2
Since FY2021: $103.1M

Assistance by fiscal year

22.7MFY2021
32MFY2022
26.9MFY2023
20.3MFY2024
672.4KFY2025
542.2KFY2026

By type

Grants$542.2K100%

Top programs

93.855 · Allergy and Infectious Diseases Research$542.2K100%

Awarding agencies

National Institutes of Health$542.2K100%
Department of Health and Human Services

Largest awards

DEVELOPMENT OF NOVEL MRNA VACCINES AGAINST MYCOBACTERIUM TUBERCULOSIS - PROJECT SUMMARY/ABSTRACT TUBERCULOSIS REMAINS ONE OF THE TOP TEN…$1.3M
93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· May 20, 2022 – Feb 11, 2026· R61AI169132
DEVELOPMENT OF NOVEL MRNA VACCINES AGAINST MYCOBACTERIUM TUBERCULOSIS - PROJECT SUMMARY/ABSTRACT TUBERCULOSIS REMAINS ONE OF THE TOP TEN…$1.2M
93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Jun 23, 2025 – Jun 9, 2026· R33AI169132

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

Sub-contracts: $6.4M (16 subawards)
Sub-grants: $477.6K (3 subawards)

7 sub-recipients

JOHNSON COUNTY CLINTRIALS LLC$2.2M31%
LENEXA, KS · 3 subawards
GEORGE WASHINGTON UNIVERSITY (THE)$2.1M30%
WASHINGTON, DC · 2 subawards
PPD DEVELOPMENT LP$768K11%
WILMINGTON, NC · 2 subawards
BRIGHAM & WOMENS HOSPITAL INC$740.6K11%
BOSTON, MA · 1 subaward
FISHER BIOSERVICES INC$534.9K7.7%
ROCKVILLE, MD · 6 subawards
TRUDEAU INSTITUTE INC$477.6K6.9%
SARANAC LAKE, NY · 3 subawards
BATAVIA BIOSCIENCES INC.$157.6K2.3%
WOBURN, MA · 2 subawards

As a sub-recipient: who pays it · FY2026

Sub-grants: $2.2M (4 subawards)

2 primes

SCRIPPS RESEARCH INSTITUTE$2.1M97%
LA JOLLA, CA · 3 subawards
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION$60K2.7%
PITTSBURGH, PA · 1 subaward

Its reported sub-contracts equal 634% of its FY2026 contract obligations.

By fiscal year

FY2021: $20.2M paid out · $10.2M received
FY2022: $31.3M paid out · $4.8M received
FY2023: $18.3M paid out · $1.6M received
FY2024: $22M paid out · $0 received
FY2025: $10.8M paid out · $356K received
FY2026: $6.9M paid out · $2.2M received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

72 companies · $109.5M reported

BATAVIA BIOSCIENCES INC.$16.7M
WOBURN, MA · 17 subawards · Scientific research and development services
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE$9.9M
LONDON, GBR · 10 subawards · Scientific research and development services
UNIVERSITY OF NAIROBI$8.1M
NAIROBI, KEN · 7 subawards

Primes that pay it

6 companies · $19.2M reported

SCRIPPS RESEARCH INSTITUTE$16.9M
LA JOLLA, CA · 12 subawards
AIDS VACCINE ADVOCACY COALITION$788.5K
NEW YORK, NY · 3 subawards
MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION$772.8K
PITTSBURGH, PA · 3 subawards

Showing the top 3 of each list. Open the profile for potential partners and the full lists.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 3 markets (agency × industry), FY2024–FY2026.

INTEGRAL MOLECULAR INC$6.5M−51% in FY2026
PHILADELPHIA, PA · 70% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
ACCESS TO ADVANCED HEALTH INSTITUTE$7.4M
SEATTLE, WA · 72% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER NEW ORLEANS$6.1M+6.1% in FY2026
NEW ORLEANS, LA · 66% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

International AIDS Vaccine InitiativeAI match · 100%

Lobbying · 2024: $200K; 4 reports
Lobbying · 2023–2025: $550K

Lobbying by year

2023$240K
4 reports
2024$200K
4 reports
2025$110K
3 reports

Top issues

Budget and appropriations11 reports
Foreign relations11 reports
Health issues11 reports

Who was contacted

State - Dept of (DOS)11 reports
U.S. HOUSE OF REPRESENTATIVES11 reports
U.S. SENATE11 reports
White House Office11 reports
Executive Office of the President (EOP)8 reports
U.S. Agency for International Development (USAID)8 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

Kyle House Group$550K
11 reports

Registrants who are individuals are counted, not named.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 10, 2026, loaded Oct 10, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Sep 30, 2026.

Congress: members and bills

Through the organizations matched to this company: members of Congress whose campaigns received contributions from their PACs, and the bills their lobbying reports named. Shown beside the company's contracts as a comparison, not a cause.

Bills named in its lobbying reports

H.R. 8771 · Department of State, Foreign Operations, and Related Programs Appropriations Act, 20253 reports
118th Congress · Passed one chamber · 2024
S. 4797 · Department of State, Foreign Operations, and Related Programs Appropriations Act, 20252 reports
118th Congress · Reported by committee · 2024
H.R. 4665 · Department of State, Foreign Operations, and Related Programs Appropriations Act, 20241 report
118th Congress · Passed one chamber · 2024
S. 2438 · Department of State, Foreign Operations, and Related Programs Appropriations Act, 20241 report
118th Congress · Reported by committee · 2024

4 of 11 reports (2023–2025) name at least one bill. Bills and resolutions the current reports name in their issue descriptions, by number of reports. A report names what it lobbied on, not which side it took.

Amounts, members and bills are as recorded, shown side by side. They say nothing about why a contribution was made, how a member voted or what a report sought. A bill number written in a report is read as the measure of the Congress its context points to (a law's number, the Congress written next to it, the title), else of the Congress then sitting.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 10, 2026, loaded Oct 10, 2026.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 10, 2026, loaded Oct 10, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.